Managed by NetworkPharma

Managed by
NetworkPharma

Facilitating Networking and Information Sharing amongst Pharmaceutical and MedComms, Medical Communications, Medical Education and Medical Publishing Specialists

This global initiative facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities.
Why not sign up to our weekly newsletter and please, help spread the word amongst all relevant others.

MORE DETAILS

  • Home
  • About us
  • Testimonials
  • Events
  • Useful Reading
  • In the News
  • Companies
  • Independents
  • Services
  • Special offers
  • Job Adverts
  • Twittering
  • Webcasts
  • Starting out
  • Weekly Newsletter
  • Weekly Comment
  • Survey data
  • Sponsors

  • MedComms Networking on Facebook

    MedComms Networking on Linkedin

    MedComms Networking on Twitter

    MedComms Networking on YouTube


    MedComms Networking is sponsored by:

    Many thanks to all the Sponsors of MedComms Networking

    WEEKLY COMMENT

    Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.


    MedComms Networking - 22 May 2018

    Hi

    The world's gone mad! My email box overflows with invitations to stay in touch - or face consequences. Talk about unintended consequences...

    I've tried to stay out of the madness that is GDPR but I guess I must write something before Friday. So please note, today, like every other day for the past 11 years, I invite you to unsubscribe if you don't want to hear from me this way anymore. The email address that is subscribed is noted and a link to unsubscribe that address is provided at the base of every email. Or just ask me to do it for you. I always do so with good grace. I shed a tear every time someone leaves with no apparent good reason, but that's all. It won't stop them - or anybody else - accessing the services I run, which are freely accessible to all. It might, though, make it a little less likely they'll hear about them. But there's plenty of other ways of staying updated. For instance, reach out to me on Linkedin, like the Facebook page, follow me on Twitter or if that all seems dangerously transparent, follow hashtag #MedComms on Twitter and you'll spot most of the important news, at least, and nobody need ever know you're paying any attention! Your choice. No one way works for everyone.

    But be realistic. I'm getting emails from people I regularly work with, asking me to jump through double opt-in hoops, to allow them to stay in touch. A freelancer I spoke with recently said they'd heard back from less than a third of their contacts who they'd asked for permission to stay in touch with. So now what happens on Saturday? Can they not contact the majority who didn't respond, most of whom may have just missed the email or been too busy?

    This newsletter will only be opened by about a third of you today, if I'm lucky and if the tracking numbers are to be believed. Next week a third again, but not the same third. I don't expect everyone to study everything in detail but it's one easy way to get word out to you. And, did I mention? You can unsubscribe, anytime. Your choice.

    These new rules aren't intended to stop us all trying to do sensible, legitimate, business with each other.

    And please don't worry, I'm happy to hear from any of you if the information is relevant. So, for instance, please continue sending your press releases. I won't complain. I'd just like to think that when the time comes, you'll gracefully stop sending them when asked.

    So, let's keep on going. Sensibly.

    Importantly we've now exceeded our target of 500 responses to the new Healthcare Communications Workforce Insight Survey 2018. We'd love even more. It only takes 5 minutes. Take a rest from those GDPR forms and join in here.

    Have a great week. For more on the GDPR madness read this; Most GDPR emails unnecessary and some illegal, say experts.

    Cheers

    Peter Llewellyn
    Managing Director, NetworkPharma Ltd
    Follow me on Twitter @NetworkPharma
    Join 4,000 international colleagues in the MedComms Networking Linkedin Group
    The information at www.MedCommsNetworking.com is always bang up-to-date!

    WHAT ELSE?

    Subscribe to the weekly MedComms Networking email newsletter here - it's entirely free of charge!


    This web site and associated activities are being managed by NetworkPharma Ltd, Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, UK
    Telephone +44 (0) 1865 784390 Email: support@networkpharma.com

    Our web sites

    [www.FirstMedCommsJob.com] [www.FreelanceMedComms.com] [www.KeywordPharma.com] [www.MedCommsDay.com]
    [www.MedCommsForum.com] [www.MedCommsNews.com] [www.MedCommsNetworking.com]
    [www.MedCommsWorkBook.com] [www.NetworkPharma.tv] [www.NextMedCommsJob.com]